Mitsios John V, Vini Maria P, Stengel Dominique, Ninio Ewa, Tselepis Alexandros D
Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece, 45110.
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1907-13. doi: 10.1161/01.ATV.0000228821.79588.ef. Epub 2006 May 25.
Platelet-activating factor acetylhydrolase (PAF-AH) expresses a Ca2+-independent phospholipase A2 activity and hydrolyzes platelet-activating factor as well as oxidized phospholipids. Two major types of PAF-AH have been described: the plasma type, which is associated with lipoproteins, and the intracellular type II PAF-AH.
We investigated the type(s) of PAF-AH expressed in human platelets as well as the mechanism and the enzyme type secreted from platelets during activation. The majority of the enzyme activity (75.1+/-14.3% of total) is found in the cytosol, whereas 24.9+/-7.3% is associated with the membranes. Immunofluorescence microscopy studies and Western blotting analysis showed that platelets contain the plasma type as well as the intracellular type II PAF-AH. Furthermore, platelets contain high levels of the mRNA of plasma PAF-AH, whereas only a small quantity of the type II PAF-AH mRNA was detected. On activation, platelets secrete the plasma type of PAF-AH mainly associated with platelet-derived microparticles (PMPs). The enzyme activity was also detected on circulating PMPs in plasma from normolipidemic healthy subjects.
This is the first indication that in addition to lipoproteins, PAF-AH in human plasma is carried by PMPs, suggesting that the PMP-associated PAF-AH may play a role in the dissemination of biological activities mediated by these particles.
血小板活化因子乙酰水解酶(PAF-AH)具有不依赖钙离子的磷脂酶A2活性,可水解血小板活化因子以及氧化磷脂。已描述了两种主要类型的PAF-AH:与脂蛋白相关的血浆型和细胞内II型PAF-AH。
我们研究了人血小板中表达的PAF-AH类型,以及血小板活化过程中分泌的机制和酶类型。大部分酶活性(占总量的75.1±14.3%)存在于胞质溶胶中,而24.9±7.3%与膜相关。免疫荧光显微镜研究和蛋白质印迹分析表明,血小板含有血浆型以及细胞内II型PAF-AH。此外,血小板含有高水平的血浆PAF-AH mRNA,而仅检测到少量的II型PAF-AH mRNA。在活化时,血小板分泌主要与血小板衍生微粒(PMPs)相关的血浆型PAF-AH。在血脂正常的健康受试者血浆中的循环PMPs上也检测到了酶活性。
这是首个表明除脂蛋白外,人血浆中的PAF-AH由PMPs携带的迹象,提示与PMPs相关的PAF-AH可能在这些微粒介导的生物活性传播中发挥作用。